Home BoRay Neurotech's Brain-Computer Interface Product Listed on Procurement Platform, Paving Way for Clinical Rollout and IPO

BoRay Neurotech's Brain-Computer Interface Product Listed on Procurement Platform, Paving Way for Clinical Rollout and IPO

Mar 26, 2026 20:20 CST Updated 20:20
Neuracle

Developer and Manufacturer of Brain-Computer Interface Systems and Related Equipment

StairMed

Developer of Implantable Brain-Computer Interface Technology

BCIFlex

Invasive High-Throughput Ultra-Thin Flexible Brain-Computer Interface System Developer

BrainCo

Non-invasive brain-computer interface technology solution provider

OYMotion

Provider of Rehabilitation Medical Technology Solutions

Medtronic

Medical Device Manufacturer

Tencent

Internet Comprehensive Service Provider

Author | Yueqing

Only 11 Days After Launch, Brain-Computer Interface Enters "Clinical Hospital Entry" Phase.

01

Implementation of Online Listing

The Era of Brain-Computer Interface 2.0 Has Arrived in China

Xinmin Evening News TodayReported onNeuracle's Implantable Brain-Computer Interface ProductCompleted the listing on the Sunshine Procurement Platform on March 24.

Since receiving approval from the National Medical Products Administration on March 13,Becoming the world's first commercially available brain-computer interface product, by March 22ndThe World's First Medical Insurance Code for Brain-Computer Interface Innovative Product, and on March 23, by the Shanghai Municipal Medical Insurance DepartmentOfficially included in the medical consumables directory and successfully listed, this product completed the critical three-stage leap in just ten days, marking the official entry of brain-computer interface in China into the commercial transformation phase.

In February this year,Neuracle Official AnnouncementLaunch the STAR MarketIPOCoaching, and打通进院渠道 will become an important factor for its IPO push. It is reported that this product is expected to achieve its first clinical application within the year.This product is mainly aimed at patients aged 18 to 60 who suffer from quadriplegia due to cervical spinal cord injury and are unable to complete grasping with their fingers.

2026, BrainMachine Interface in ClinicalBed andThe market has fully exploded on both ends.The research report of Open Source Securities shows,Brain-computer interface technology will move towards commercialization by 2026, transitioning from essential medical needs to AI applications.RobotPenetration into multiple fields

BesidesIn addition to Neuracle's remarkable achievements, this popular track has seen a constant stream of significant updates recently.

Just CompletedRMB 500 million strategic financingStairMedIt was revealed that a large-scale, multi-center registration clinical trial is planned to be launched in mid-2026, with completion expected within the same year.Achieve a certain scale of patient enrollment and implant surgeries, becoming the successorAfter NeuralinkThe world's second company to enter the clinical stage in invasive brain-computer interface.

Focus on Ultrasound Brain-Computer InterfaceTheGestalt TechnologyCompleted an angel round of financing worth 150 million yuan, setting a new record for the highest angel round in China's brain-computer interface field.BCIFlexBCIFlex has recently completed a 300 million yuan A+ round of financing, achieving 600 million in funding within half a year.

The commercial potential of the non-invasive track has also gained capital recognition, asA strong contender for the title of China's first brain-computer interface stock,BrainCoLatest valuation exceeds 12 billion RMBOYMotionOYMotionAnnounced on March 25 the completion of a C1 round of financing worth 150 million yuan,Brain-Computer Interface and Embodied Intelligence Synergy.

According to statistics from Intelligence Medicine Bureau,As of February 2026, the number of core brain-computer interface companies in China has reached 47.. According to Qichacha data,As of January 2026, there are 654 brain-computer interface related companies in China.

In China, the brain-computer interface industry has entered a phase of flourishing development.

02

Full-Cycle Policy "Support"

Brain-Computer InterfaceOral CompletionBusiness Closed Loop

The capital is booming and absorbingAttract more players to enter the market, in addition to the aforementioned vertical enterprises, Medtronic,Medical device giants in and outside of China, such as HeartCare Medical, are also highly focused on this track. Tech giants like Alibaba and Tencent are equally eager to make their moves, taking on the role of investors to get a head start in strategic planning.

Barnes RePORTS LatestThe report shows,The Market Size of BCI in China Will Reach 1.053 Billion US Dollars in 2026, this figure is almost twice that of the U.S. market ($578 million).

For medical device products with high technological barriers, policy support is an important guarantee for sustainable development.

The "15th Five-Year Plan" recommends listing brain-computer interface as one of the six future industriesBrain-computer interface was also highlighted in the 2026 government work report.In recent years, the actions taken from the national to local levels show that brain-computer interface has gained full-chain support.

Focusing on the hospital entry process, in September last year, the National Healthcare Security Administration publicly solicited information on innovative medical consumables products such as brain-computer interfaces, and in March this year...Neuracle AchievesThe World's FirstAchievement of Obtaining Medical Insurance Coding, and the second and third are expected to be put on the agenda.

At the payment port, the in-hospital charging chain for brain-computer interfaces has now been established.Xiangyu MedicalIn response to inquiries from researchers, the National Healthcare Security Administration will issue guidelines on charging for brain-computer interface rehabilitation in early 2025. Currently, more than 20 provinces and municipalities in China have introduced relevant charging standards for brain-computer interfaces, fully demonstrating the country's support for the development of the brain-computer interface industry.

Taking Beijing as an example,The implantation fee for invasive brain-computer interfaces isRMB 7,980 per session,An additional 30% charge for children;The implantation fee for semi-invasive (epidural) brain-computer interfaces is charged at 4,800 yuan.

With the entry into the hospital"The last mile" has been打通, and brain-computer interface technology has moved from technical validation to a new phase of large-scale commercial implementation.2026 may become the first year of industrialization for brain-computer interfaces in China.